vs

Side-by-side financial comparison of Axos Financial, Inc. (AX) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $392.2M, roughly 1.7× Axos Financial, Inc.). Axos Financial, Inc. runs the higher net margin — 31.8% vs 7.1%, a 24.7% gap on every dollar of revenue. Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 16.1%).

Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

AX vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.7× larger
NTRA
$665.5M
$392.2M
AX
Higher net margin
AX
AX
24.7% more per $
AX
31.8%
7.1%
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
16.1%
AX

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AX
AX
NTRA
NTRA
Revenue
$392.2M
$665.5M
Net Profit
$124.7M
$47.3M
Gross Margin
Operating Margin
-3.4%
Net Margin
31.8%
7.1%
Revenue YoY
39.8%
Net Profit YoY
18.5%
187.9%
EPS (diluted)
$2.15
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AX
AX
NTRA
NTRA
Q1 26
$392.2M
Q4 25
$385.1M
$665.5M
Q3 25
$323.4M
$592.2M
Q2 25
$321.4M
$546.6M
Q1 25
$308.8M
$501.8M
Q4 24
$307.9M
$476.1M
Q3 24
$320.7M
$439.8M
Q2 24
$290.9M
$413.4M
Net Profit
AX
AX
NTRA
NTRA
Q1 26
$124.7M
Q4 25
$128.4M
$47.3M
Q3 25
$112.4M
$-87.5M
Q2 25
$110.7M
$-100.9M
Q1 25
$105.2M
$-66.9M
Q4 24
$104.7M
$-53.8M
Q3 24
$112.3M
$-31.6M
Q2 24
$104.9M
$-37.5M
Operating Margin
AX
AX
NTRA
NTRA
Q1 26
Q4 25
45.6%
-3.4%
Q3 25
46.3%
-16.5%
Q2 25
48.5%
-20.2%
Q1 25
47.9%
-15.8%
Q4 24
48.8%
-13.6%
Q3 24
49.6%
-8.9%
Q2 24
49.6%
-10.6%
Net Margin
AX
AX
NTRA
NTRA
Q1 26
31.8%
Q4 25
33.3%
7.1%
Q3 25
34.7%
-14.8%
Q2 25
34.4%
-18.5%
Q1 25
34.1%
-13.3%
Q4 24
34.0%
-11.3%
Q3 24
35.0%
-7.2%
Q2 24
36.0%
-9.1%
EPS (diluted)
AX
AX
NTRA
NTRA
Q1 26
$2.15
Q4 25
$2.22
$0.36
Q3 25
$1.94
$-0.64
Q2 25
$1.89
$-0.74
Q1 25
$1.81
$-0.50
Q4 24
$1.80
$-0.41
Q3 24
$1.93
$-0.26
Q2 24
$1.75
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AX
AX
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$3.1B
$1.7B
Total Assets
$29.2B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AX
AX
NTRA
NTRA
Q1 26
Q4 25
$1.0B
Q3 25
$2.6B
$1.0M
Q2 25
$1.9B
$16.0M
Q1 25
$2.0B
$17.8M
Q4 24
$2.4B
$22.7M
Q3 24
$2.6B
$29.5M
Q2 24
$2.0B
$90.3M
Total Debt
AX
AX
NTRA
NTRA
Q1 26
Q4 25
Q3 25
Q2 25
$312.7M
Q1 25
$377.4M
Q4 24
$358.7M
Q3 24
$313.5M
Q2 24
$325.7M
Stockholders' Equity
AX
AX
NTRA
NTRA
Q1 26
$3.1B
Q4 25
$2.9B
$1.7B
Q3 25
$2.8B
$1.3B
Q2 25
$2.7B
$1.2B
Q1 25
$2.6B
$1.2B
Q4 24
$2.5B
$1.2B
Q3 24
$2.4B
$878.5M
Q2 24
$2.3B
$836.5M
Total Assets
AX
AX
NTRA
NTRA
Q1 26
$29.2B
Q4 25
$28.2B
$2.4B
Q3 25
$27.4B
$1.8B
Q2 25
$24.8B
$1.8B
Q1 25
$24.0B
$1.7B
Q4 24
$23.7B
$1.7B
Q3 24
$23.6B
$1.6B
Q2 24
$22.9B
$1.5B
Debt / Equity
AX
AX
NTRA
NTRA
Q1 26
Q4 25
Q3 25
Q2 25
0.12×
Q1 25
0.14×
Q4 24
0.14×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AX
AX
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AX
AX
NTRA
NTRA
Q1 26
Q4 25
$104.1M
$73.9M
Q3 25
$118.4M
$59.4M
Q2 25
$490.3M
$37.6M
Q1 25
$73.7M
$44.5M
Q4 24
$162.5M
$52.9M
Q3 24
$70.8M
$51.8M
Q2 24
$305.5M
$4.0M
Free Cash Flow
AX
AX
NTRA
NTRA
Q1 26
Q4 25
$85.4M
$37.8M
Q3 25
$109.3M
$37.0M
Q2 25
$436.1M
$11.7M
Q1 25
$65.1M
$22.6M
Q4 24
$156.4M
$34.8M
Q3 24
$53.0M
$35.5M
Q2 24
$269.5M
$-7.7M
FCF Margin
AX
AX
NTRA
NTRA
Q1 26
Q4 25
22.2%
5.7%
Q3 25
33.8%
6.2%
Q2 25
135.7%
2.1%
Q1 25
21.1%
4.5%
Q4 24
50.8%
7.3%
Q3 24
16.5%
8.1%
Q2 24
92.6%
-1.9%
Capex Intensity
AX
AX
NTRA
NTRA
Q1 26
Q4 25
4.9%
5.4%
Q3 25
2.8%
3.8%
Q2 25
16.9%
4.7%
Q1 25
2.8%
4.3%
Q4 24
2.0%
3.8%
Q3 24
5.5%
3.7%
Q2 24
12.4%
2.8%
Cash Conversion
AX
AX
NTRA
NTRA
Q1 26
Q4 25
0.81×
1.56×
Q3 25
1.05×
Q2 25
4.43×
Q1 25
0.70×
Q4 24
1.55×
Q3 24
0.63×
Q2 24
2.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AX
AX

Net Interest Income$306.3M78%
Noninterest Income$86.0M22%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons